Pure Global

AMYLASE TEST KIT(LIQUIZYME α AMYLASE ) - India CDSCO Medical Device Registration

AMYLASE TEST KIT(LIQUIZYME α AMYLASE ) is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd. This device is marketed under the brand name SEROCON CYSTATIN C CONTROL SET. The license holder is Beacon Diagnostics Pvt. Ltd., and it is classified as Device Class Class B. The approving authority is Gujarat.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class B
AMYLASE TEST KIT(LIQUIZYME α AMYLASE )
UID: MFG/MD/2020/000017_f521612de7df9d7735464c5b7be81a56_ae94a1a64cd0b45c0cc4ac84114e57bd

Brand Name

SEROCON CYSTATIN C CONTROL SET

Device Class

Class B

Approving Authority

Gujarat

Product Information

For the quantitative determination of alpha-Amylase in human serum, plasma and urine

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing